Press Releases

Summary Toggle Chembio to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7, 2014

Aug 6, 2014

Category: Baystreet Newswire Company: Issuer Direct ID: 418805 Date: Wednesday, August 06, 2014 Ticker: NASDAQ:CEMI MEDFORD, NY / ACCESSWIRE / August 6, 2014 / Chembio Diagnostics, Inc. (NASDAQ:CEMI) will host a conference call and live webcast to discuss the results of the second quarter 2014, to
Read more

Chembio to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7, 2014 32.1 KB
Summary Toggle Chembio to Host Conference Call to Discuss Second Quarter 2014 Financial Results

Jul 24, 2014

Conference Call Scheduled for Thursday, August 7th at 10:00a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss Second Quarter 2014 Financial Results 34.4 KB
Summary Toggle Chembio Launches U.S. Sales and Marketing Initiative

Jun 4, 2014

Chembio Now Marketing HIV 1/2 STAT-PAK(R) and DPP(R) HIV 1/2 Assays

Read more

Chembio Launches U.S. Sales and Marketing Initiative 34.6 KB
Summary Toggle Chembio Diagnostics To Sponsor 2014 AIDS Walk New York

May 16, 2014

Chembio to Ring NASDAQ Closing Bell Today with AIDS Walk

Read more

Chembio Diagnostics To Sponsor 2014 AIDS Walk New York 33.9 KB
Summary Toggle Chembio Diagnostics Reports First Quarter 2014 Financial Results

May 8, 2014

Conference Call and Webcast Today at 10:00 a.m. Eastern

Read more

Chembio Diagnostics Reports First Quarter 2014 Financial Results 46.8 KB
Summary Toggle Chembio to Host Conference Call to Discuss First Quarter 2014 Financial Results

Apr 24, 2014

Conference Call Scheduled for Thursday, May 8th at 10:00a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss First Quarter 2014 Financial Results 34 KB
Summary Toggle Chembio Terminates U.S. Distribution Agreement With Alere

Apr 7, 2014

Announces Plan to Build U.S. Sales & Marketing Team

Read more

Chembio Terminates U.S. Distribution Agreement With Alere 33.8 KB
Summary Toggle Chembio Names Katherine L. Davis Chairman of the Board

Mar 28, 2014

MEDFORD, N.Y. , March 28, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today named Katherine L. Davis as the Company's non-executive Chairman of the Board. Ms.
Read more

Chembio Names Katherine L. Davis Chairman of the Board 34.7 KB
Summary Toggle Chembio's HIV 1/2 STAT-PAK(R) Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV

Mar 25, 2014

MEDFORD, N.Y. , March 25, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that its HIV 1/2 STAT-PAK® Assay received CE Mark approval from European regulators.
Read more

Chembio's HIV 1/2 STAT-PAK(R) Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV 35.8 KB
Summary Toggle John Sperzel Appointed as President and CEO of Chembio Diagnostics

Mar 14, 2014

MEDFORD, N.Y., March 14, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced the appointment of John Sperzel as President and CEO, effective March 13, 2014.
Read more

John Sperzel Appointed as President and CEO of Chembio Diagnostics 33.6 KB